Results 91 to 100 of about 6,037,566 (297)

Association of maternal and umbilical cord blood leptin concentrations and abnormal color Doppler indices of umbilical artery with fetal growth restriction

International Journal of Reproductive BioMedicine, 2017
Background: Fetal growth restriction (FGR) is a condition with heterogeneous pathophysiology which characterized by fetal weight less than the tenth percentile for gestational age.
Elahe Zareaan, Mitra Heidarpour, Elham Kargarzadeh   +2 more
doaj   +2 more sources

Decidual macrophages and Hofbauer cells in fetal growth restriction

Frontiers in Immunology
Placental macrophages, which include maternal decidual macrophages and fetal Hofbauer cells, display a high degree of phenotypical and functional plasticity.
Romy Elisa Bezemer, Romy Elisa Bezemer, Marijke M. Faas, Marijke M. Faas, Harry van Goor, Sanne Jehanne Gordijn, Jelmer R. Prins   +6 more
doaj   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source

Maternal serum copeptin as a marker for fetal growth restriction

Middle East Fertility Society Journal, 2013
Objectives: Copeptin is a hormone of endogenous stress. The aim was to evaluate whether the measurement of maternal serum copeptin is useful for differentiation between fetal growth retardation and constitutionally small fetuses among small for ...
Ashraf A. Foda, Ibrahim A. Abdel Aal
doaj   +1 more source

Sildenafil citrate for the management of fetal growth restriction and oligohydramnios

, 2016
Rana Choudhary,1 Kavita Desai,2 Hetal Parekh,3 Kedar Ganla1 1Department of Reproductive Medicine, Ankoor Fertility Clinic, 2Department of Radiology, Dadar Imaging and Diagnostic Centre, 3IVF Department, Hiranandani Hospital, Mumbai, India Abstract ...
Choudhary R, Ganla K, Desai K, Parekh H
core  

The Neurovascular Unit in Fetal Growth Restriction

, 2023
This thesis examines the development of the neurovascular unit, a collection of cells and surrounding structures controlling blood flow within the brain.
ALEXANDER HENRY BELL (15216007)
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

Neurocognitive outcome following fetal growth restriction

, 2008
This review evaluates neurological and cognitive outcomes as they relate to fetal growth restriction. The aim is to clarify the relationship between poor fetal growth and abnormal brain development in order to understand the research directions required ...
Walker, D. M., Marlow, N.
core   +1 more source

Can fetal fractions in the cell-free DNA test predict the onset of fetal growth restriction?

, 2020
Objective: To investigate the possible predictive value of fetal fraction in the cell-free DNA (cfDNA) test in pregnancies with early- and late-onset fetal growth restriction (FGR)
Koc, Altug, Kaya, Ozge Ozer, Ekin, Atalay, Kuyucu, Melda, Toklu, Gizem, Ozdemir, Taha Resid, Adiyaman, Duygu, Atakul, Bahar Konuralp, Golbasi, Hakan   +8 more
core   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

Molecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir, Elena Haro‐Martínez, Sandra Blasco‐Benito, Chiara Cannatà, José Ángel Palomeque, Anna López‐Plana, Maria Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià‐Terrassa   +9 more
wiley   +1 more source